The electronic Onco-Haematological clinical record DOSSIER puts the patient at the center of a safe and integrated system, supporting all the specialists involved in the whole care route.
ITS SPECIAL FEATURES
Oncology, Hematology, Pediatric Onco-Hematology, Pharmacy and Molecular Biology Laboratory.
MYRIAPOD® - From molecular biology to applied clinical
It allows the integration between pathological anatomy and oncology, managing the laboratory data, clinical data, medical history data and personal patient data. Using the results of pharmacogenetic research, which studies the individual response to drugs, it supports the clinician in the development of personalized therapy.
INTERACTION BETWEEN DRUGS
It points out interactions between the active ingredients of prescribed drugs
ELECTRONIC NURSING CLINICAL RECORD
Care process in stages (according to the functional model of Marjory Gordon)
PICC | MIDLINE
Planning of PICC / MIDLINE placements and intervention boards
Site of the tumors, Histological typing, biomolecular markers, histologic grade, Ratings (TNM, UICC, FIGO, DUKES, MAC), AIEOP Classifications, Toxicity Criteria (NCI-CTC 3.0), Pharmaceutical Handbook
DESIGNED WITH CLINICIANS
The design in harmony with health professionals, thanks to continued collaboration with main actors in the management of the patient, DOSSIER is constantly upgraded, improving its content and its functionality
Comply with the guidelines of the Italian Association of Medical Oncology (AIOM)
Complies with the standards and the procedures JACIE (Joint Accreditation Committee-ISCT & EBMT)
A short presentation of the product: